News - MedTech

Silence Therapeutics wins US backer as it seeks to delist from AIM

A London MedTech which is looking to delist from the London Stock Exchange’s alternative AIM marke...

Diabetes startup Occuity rejuvenates key designer behind iPhone

A key member of the design team behind Apple's flagship products is now tackling diabetes. Daniel...

£13m investment for MedTech Closed Loop Medicine

Closed Loop Medicine has closed £13 million of new investment from a range of top UK and European v...

Insomnia startup SleepCogni to launch in US

SleepTech startup SleepCogni has raised £1.4 million to scale the business to commercialise into th...

Could listed BiVictriX Therapeutics deliver cancer breakthrough?

BiVictriX Therapeutics, led by 33-year-old CEO Tiffany Thorn, is trying to fix one of the longest-st...

Arm founder appointed chair of MedTech bit.bio

A co-founder of chipmaking giant Arm has been appointed chairman of Cambridge MedTech bit.bio. Dr...

Oxford BioDynamics share placing to boost COVID, cancer tests

Oxford BioDynamics has raised £3.6 million in a share placing. The listed biotechnology company ...

This tech-powered T-shirt could save your life

A wearable ECG monitoring vest aimed at people with abnormal heartbeats - arrhythmia - has been crea...

Firm behind COVID ‘sugar test’ appoints new CEO

Iceni Diagnostics has appointed a new CEO as the company prepares to bring its revolutionary product...

£9m to launch at-home blood testing tech tackling cancer

MedTech Entia has raised close to £9 million to launch an at-home blood testing solution for cancer...

Implantable heart tech predicts a patient’s risk of dying

Implantable heart technology is being used in Manchester to assess when a patient is at high risk of...

Oxford Nanopore launches £3.4bn IPO in London

Oxford Nanopore Technologies has floated on the main market of the London Stock Exchange. With an...

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.